Median Technologies Revenue and Competitors

Valbonne, USA

Location

#4837

Growjo Ranking

3D

Industry

Estimated Revenue & Valuation

  • Median Technologies's estimated annual revenue is currently $53.5M per year.(i)
  • Median Technologies's estimated revenue per employee is $187,000

Employee Data

  • Median Technologies has 286 Employees.(i)
  • Median Technologies grew their employee count by 6% last year.

Median Technologies's People

NameTitleEmail/Phone
1
Executive Director Business DevelopmentReveal Email/Phone
2
COO USReveal Email/Phone
3
Chief HR, Administration and ProcurementReveal Email/Phone
4
Chief Human Resources & Corporate ServicesReveal Email/Phone
5
Chief Operations, iCRO at Median TechnologiesReveal Email/Phone
6
Head Software DevelopmentReveal Email/Phone
7
Head Imaging Lab - iCROReveal Email/Phone
8
Head Quality AssuranceReveal Email/Phone
9
Head Project Management for imaging CROReveal Email/Phone
10
Head Business Support and Customer ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M110%N/AN/A
#2
$5780M77268%N/AN/A
#3
$24270M2786321%$4BN/A
#4
$207.3M871N/AN/AN/A
#5
$5.4M40-20%N/AN/A
#6
$3M2532%N/AN/A
#7
$5.8M43-12%N/AN/A
#8
$16.5M97-8%$27.6MN/A
#9
$15.3M90-10%$43.6MN/A
#10
$0.6M150%$7.5MN/A
Add Company

What Is Median Technologies?

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions for medical image analysis and management in oncology clinical trials and our investigational imaging phenotyping platform iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris' Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup.

keywords:N/A

N/A

Total Funding

286

Number of Employees

$53.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Median Technologies News

2022-04-19 - Median Technologies Reports Full-Year 2021 Results and ...

About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness...

2022-04-06 - Global Imaging Biomarkers Market (2022 to 2027) - Featuring ...

Median Technologies; PI Solutions Group GmbH; IXICO plc; Bioxydyn Ltd. Zionexa; Imabiotech; BRAINOMIX. A biomarker is a biological molecule...

2022-03-30 - Median Technologies (EPA:ALMDT) shareholder returns have been massive, earning 970% in 3 years

Median Technologies isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying...

2021-10-21 - Median Technologies : Half-year financial report 2021

Half-Year Financial Report June 30, 2021 Median Technologies SA This is a free translation into English of the Financial Report issued in French and it is provided solely for the convenience of English-speaking users. 1. PRESENTATION OF THE GROUP SUMMARY 1. PRESENTATION OF THE GROUP ..... ...

2021-09-06 - Median Technologies : announces outstanding performance for its iBiopsy® Lung Cancer Screening CADx to accurately characterize malignant vs benign lung nodules based on a large-scale patient cohort

Press release - For immediate release September 06, 2021 - 05:45 pm CEST Median Technologies announces outstanding performance for its iBiopsy® Lung Cancer Screening CADx1 to accurately characterize malignant vs benign lung nodules based on a large-scale patient cohort Results show cutting-ed ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$101.9M38828%N/A